RCG
AMGN icon

Ruane, Cunniff & Goldfarb’s Amgen AMGN Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,017
Closed -$327K – 134
2015
Q4 		$327K Hold
2,017
– – ﹤0.01% 127
2015
Q3 		$279K Buy
2,017
+400
+25% +$63.1K ﹤0.01% 135
2015
Q2 		$248K Hold
1,617
– – ﹤0.01% 137
2015
Q1 		$258K Hold
1,617
– – ﹤0.01% 139
2014
Q4 		$258K Hold
1,617
– – ﹤0.01% 139
2014
Q3 		$227K Buy
+1,617
New +$211K ﹤0.01% 148

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's AMGN Position: Q1 2016 in Review

Ruane, Cunniff & Goldfarb sold out of Amgen (AMGN) in Q1 2016, closing a stake of 2,017 shares — an estimated $327K sold.

Ruane, Cunniff & Goldfarb first reported a position in AMGN in Q3 2014 and held it in 6 quarters. The position peaked at $327K in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Ruane, Cunniff & Goldfarb reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Ruane, Cunniff & Goldfarb sold 2,017 Amgen shares in Q1 2016, an estimated $327K.
  • Ruane, Cunniff & Goldfarb first reported a position in Amgen in Q3 2014 and held it in 6 quarters.
  • Ruane, Cunniff & Goldfarb's Amgen position peaked at $327K in Q4 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q1 2016, filed 16 May 2016.